Literature DB >> 6175313

Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitor.

L C Petersen, I Clemmensen.   

Abstract

The progressive inhibition of plasmin by pancreatic trypsin inhibitor and by alpha 2-plasmin inhibitor in the presence of D-valyl-L-leucyl-L-lysine 4-nitroanilide was investigated. The kinetics with plasmin were compared with those with miniplasmin. The kinetic properties of two functionally different forms of alpha 2-plasmin inhibitor described by Clemmensen [(1979) in The Physiological Inhibitors of Coagulation and Fibrinolysis (Collen. D., Wiman, B & Verstraete, M., eds.), pp 131-136, Elsevier, Amsterdam] were characterized. The two forms differ in their plasminogen-binding capability, and this difference can account for a difference in secondary site interaction suggested from the kinetics. The binding of inhibitor to miniplasmin is a simple pseudo-first-order reaction with both pancreatic trypsin inhibitor and the two alpha 2-plasmin inhibitor forms. Such simple kinetics are also observed for the reaction between plasmin and the non-plasminogen-binding form of alpha 2-plasmin inhibitor. More complicated kinetics are obtained for the reaction between plasmin and the alpha 2-plasmin inhibitor form that binds to plasminogen. With both forms of the alpha 2-plasmin inhibitor, a complex stable to acetic acid/urea and gel electrophoresis is present and fully developed 15 s after initiation of the reaction with plasmin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6175313      PMCID: PMC1163341          DOI: 10.1042/bj1990121

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma.

Authors:  U Christensen; I Clemmensen
Journal:  Biochem J       Date:  1978-11-01       Impact factor: 3.857

2.  Kinetic properties of the primary inhibitor of plasmin from human plasma.

Authors:  U Christensen; I Clemmensen
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

3.  On the kinetics of the reaction between human antiplasmin and plasmin.

Authors:  B Wiman; D Collen
Journal:  Eur J Biochem       Date:  1978-03-15

4.  On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin.

Authors:  B Wiman; L Boman; D Collen
Journal:  Eur J Biochem       Date:  1978-06-01

5.  The primary inhibitor of plasmin in human plasma.

Authors:  S Müllertz; I Clemmensen
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

6.  Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasma.

Authors:  B Wiman; D Collen
Journal:  Eur J Biochem       Date:  1977-08-15

7.  Enzymic properties of the neo-plasmin-Val-422 (miniplasmin).

Authors:  U Christensen; L Sottrup-Jensen; S Magnusson; T E Petersen; I Clemmensen
Journal:  Biochim Biophys Acta       Date:  1979-04-12

8.  Rate of activation and electrophoretic mobility of unmodified and partially degraded plasminogen. Effects of 6-aminohexanoic acid and related compounds.

Authors:  S Thorsen; S Müllertz
Journal:  Scand J Clin Lab Invest       Date:  1974-10       Impact factor: 1.713

9.  Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound.

Authors:  B Wiman; P Wallén
Journal:  Eur J Biochem       Date:  1973-07-02

10.  Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.

Authors:  M Moroi; N Aoki
Journal:  J Biol Chem       Date:  1976-10-10       Impact factor: 5.157

View more
  7 in total

1.  Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.

Authors:  L C Petersen; J Brender; E Suenson
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

2.  alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.

Authors:  C Kluft; H K Nieuwenhuis; D C Rijken; E Groeneveld; G Wijngaards; W van Berkel; G Dooijewaard; J J Sixma
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

3.  Alpha 2-macroglobulin is the primary inhibitor of miniplasmin in vitro and in vivo in the mouse. Comparison with alpha 2-antiplasmin in simultaneous reaction experiments.

Authors:  S L Gonias; N L Figler
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

4.  Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.

Authors:  S Thorsen; S Müllertz; E Suenson; P Kok
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

5.  Determination of Michaelis parameters from differentials of progress curves.

Authors:  L C Petersen
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857

6.  Electrostatic interactions in the heparin-enhanced reaction between human thrombin and antithrombin.

Authors:  L C Petersen; M Jørgensen
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

7.  Criteria for the Specific Measurement of Plasmin Inhibitor Activity Using an Enzymatic Procedure.

Authors:  Piet Meijer; Michel Hanss; Ulla Christensen; Bjorn Wiman; Kees Kluft
Journal:  EJIFCC       Date:  2001-07-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.